Trending
Berberine cut triglycerides by roughly 0.37 mmol/L in a meta-analysis of 4 trials — but only 2 of those studies saw a benefit, leaving the overall evidence low.
This pooled result is a signal worth watching, not a settled fact: a systematic review found berberine lowered triglycerides, fasting glucose, and waist circumference in metabolic syndrome, yet half the individual studies saw no effect, and the overall evidence grade is weak.
Researchers combined data from four small placebo-controlled trials of berberine in people with metabolic syndrome and found a statistically significant reduction in triglycerides (about 32 mg/dL on average), plus improvements in blood sugar and waist size. However, two of the four studies reported no triglyceride benefit, and the overall quality of the evidence is rated low, so the effect is not consistent or proven enough to rely on yet.
Where this fits in the evidence
Pillser has synthesized 4 studies on Berberine for Reduced Triglyceride Levels — overall evidence strength: Low.
Across 4 studies, the evidence for berberine reducing triglyceride levels is mixed: 2 studies reported beneficial effects (one with moderate effect size, one with small), while 2 high-quality RCTs (one among Chinese men with hyperlipidemia, one among type 2 diabetes patients) found no difference between berberine and placebo, showing neutral small effects. The median study duration was 84 days (12 weeks), and the most-studied dose was approximately 1000–1200 mg/day. The predominant effect direction is mixed (beneficial and neutral), with a small to moderate effect size observed in the beneficial studies.
The study
- Systematic Review
- 2025-07-16
- Frontiers in pharmacology
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.